William V. Tamborlane, MD, chief of Yale Medicine Pediatric Endocrinology, is a highly respected endocrinologist who cares for children, adolescents and young adults with type 1 diabetes. His accomplishments, including pioneering studies in the development of insulin pump therapy in the late 1970s, have given him an international reputation as one of the most highly regarded clinical scientists in childhood diabetes and related disorders.
In addition to his own clinical practice, Dr. Tamborlane leads a multidisciplinary team of Yale Medicine physicians, diabetes nurse educators, dieticians and social workers that care for more than 1,000 children, adolescents and young adults with diabetes. His team approach utilizes advanced technology, including continuous glucose monitoring and insulin pumps. “The primary aim of intensive management of type 1 diabetes is to keep blood sugar levels as close to normal as possible in order to delay or prevent the long-term vascular and neuropathic complications of diabetes,” he says.
Yale’s Pediatric Type 1 Diabetes Research Group, which Dr. Tamborlane is a part of, continues to be at the forefront of virtually every new advance in the treatment of diabetes, “from pioneering artificial pancreas studies to transplantation of insulin-secreting cells derived from embryonic stem cells,” he says.
A professor of pediatrics (endocrinology) at Yale School of Medicine, Dr. Tamborlane has also contributed to improving diabetes care in leadership roles on a national level. He is frequently recognized as one of the best doctors in America by organizations that conduct peer surveys. Some of the most gratifying moments of his career have been when former patients tell him how much they appreciated the care they received from his team when they were children.